The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: FTSE 100 Hits High As US Fed Not "Impatient" For Rate Hike

Thu, 19th Mar 2015 11:30

LONDON (Alliance News) - The following is a summary of top news stories Thursday.
----------
COMPANIES
----------
Next reported a sixth consecutive year of annual pretax profit growth, as sales increased in its stores and particularly online, but it cut its sales guidance for the current year as it predicted slower growth in international sales due to the issues in Russia and Ukraine and due to tough overall comparative figures. Next reported a pretax profit of GBP794.8 million for the year to January 31, up from GBP695.2 million a year earlier, while excluding a GBP12.6 million gain that included a profit on the sale of its investment in Cotton Traders, pretax profit rose to GBP782.2 million from GBP695.2 million. Revenue grew 6.9% to GBP4.00 billion, from GBP3.74 billion, with Directory sales up 12.1% and retail sales up 4.8%.
----------
AstraZeneca said it will co-commercialise its Movantik treatment for opioid-induced constipation in adults with chronic non-cancer pain with Daiichi Sankyo Inc, in line with its recent strategy of developing and commercialising drugs on its own as well as through partnerships. Under the deal, Daiichi Sankyo will pay a USD200 million up-front fee and subsequent sales-related payments of up to USD625 million. AstraZeneca will be responsible for manufacturing, will book all sales and will make sales-related commission payments to Daiichi Sankyo. Both companies will be jointly responsible for commercial activities.
----------
BHP Billiton said it has priced a five-year AUD1.0 billion note issued under the company's Australian medium-term note programme. It said the Australian dollar notes will pay interest at 3.00% and mature in March 2020. The proceeds will be used for general corporate purposes.
----------
UK telecoms regulator Ofcom confirmed a new rule requiring BT Group to maintain a sufficient margin between its wholesale and retail superfast broadband prices, although it will not be imposing any changes to BT's prices at this time as it is currently meeting the requirements of the new rule. BT is required to allow other operators to use its network to sell broadband to customers, and the new rule is intended to make sure that competitors can match BT's own broadband prices profitably. However Ofcom's indicative assessment of the market shows BT's margin is sufficient under the new rule, so as such it is considered a "safeguard" to stop BT reducing retail margins in the future, and makes sure that increases in BT's costs are reflected in its prices.
----------
Sky has announced an unseasonal increase to the price of its television packages, the Financial Times reported, coming just over a month after the broadcaster paid GBP4.2 billion to secure live Premier League rights. The company, which traditionally increases its prices in September, is to increase the average price of packages by GBP2.50 per month, with the cost of a Sport bundle to increase by GBP1 to GBP47 per month.
----------
Ted Baker reported further growth in profit and sales in its last financial year, and said it plans to open more stores in the year ahead. Pretax profit grew 25.3% to GBP48.8 million in the year ended January 31, from GBP38.9 million a year earlier, as revenue grew 20.4% to GBP387.6 million, from GBP321.9 million. It raised its total dividend for the year to 40.3 pence per share from 33.7p. The fashion retailer has been having a successful few years, as the brand has continued to expand internationally leveraging its British identity, and has kept its strategy of not discounting its goods and by using word of mouth rather than expensive marketing campaigns to promote itself.
----------
Ophir Energy said it swung to a pretax profit in 2014, bolstered by a USD671.7 million gain after the sale of its interest in three blocks in Tanzania. In a statement, the company said it made a USD288.5 million pretax profit in 2014, compared with a USD280.5 million pretax loss in the prior year. The move into the black was enabled by the sale of its 20% stake in blocks one, three and four in Tanzania, for USD1.29 billion before tax to Pavilion Energy PLC. The gain registered on the farm-out more than offset an increase in exploration expenses to USD333.8 million from USD229.1 million. That was also helped by other operating expenses including administration.
----------
Property adviser Savills hiked its dividend payout as its pretax profit pushed higher in 2014 on the back of stronger revenue, with the company boosted by a strong London market, a recovery in the UK regional property market and a good performance in the US. Savills said its pretax profit for the year was GBP84.7 million, up from GBP70.1 million a year earlier. On the back of the rise in profit, the company has proposed a hike to its final dividend to 7.25 pence, from 7.00 pence, and said its total dividend payout for the year will be 23 pence per share, up 21% year-on-year, on the back of a further 12 pence supplementary dividend the company will pay based on the underlying performance of its transaction advisory business.
----------
Luxury shoe and accessories maker Jimmy Choo reported a narrowed pretax loss for 2014 thanks to a debt-for-equity swap deal it did last autumn, and its closely-watched revenue and operating earnings rose as its goods continued to prove popular and it opened more new stores, mainly in China, and renovated others. In its maiden set of annual results as a listed company, Jimmy Choo reported a pretax loss of GBP8.3 million for 2014, compared with the GBP21.4 million loss it posted in 2013, as finance costs dropped by GBP20 million following a debt-for-equity swap that it did last October. That meant its debt stood at GBP125.6 million at the end of 2014, down from GBP582.4 million a year earlier.
----------
Rentokil Initial said it has expanded its pest control business with the acquisition of US firm Eradico Services Inc and Sagrip SA, which will give the company a presence in the Guatemala and El Salvador markets. The FTSE 250-listed business services company did not provide any financial details on the acquisitions, but said the two businesses produced combined annual revenue of GBP7.3 million in the 12 months prior to the acquisition.
----------
Housebuilder Crest Nicholson Holdings said it has seen a strong start to the spring selling season and is confident of meeting its targets for the year. In a short statement ahead of the company's annual general meeting, Crest Nicholson Chairman William Rucker said the company's spring selling season has been strong since it published in January its results for the year to the end of October.
----------
MARKETS
----------
The FTSE 100 is trading in the green, having hit a new record intraday high of 6,982.79 earlier in the session, led by resource stocks as investors continue to focus on the outcome of Wednesday's US Federal Reserve meeting.
----------
FTSE 100: up 0.2% at 6,955.37
FTSE 250: up 0.3% at 17,413.28
AIM ALL-SHARE: flat at 715.35
----------
GBP-USD: down at USD1.4914
EUR-USD: down at USD1.0694

GOLD: down at USD1165.01 per ounce
OIL (Brent): down at USD51.34 a barrel

(changes since end of previous GMT day)
----------
ECONOMICS AND GENERAL
----------
The US Federal Reserve said a hike in its benchmark interest rate "remains unlikely" for the central-bank's April 29 meeting, but said nothing about the following meeting in June. In a statement, the Fed dropped its recent outlook of being "patient in beginning to normalize" monetary policy from its unprecedented near-zero rate, in place for nearly seven years. The Fed "anticipates that it will be appropriate to raise the target range for the federal funds rate when it has seen further improvement in the labour market and is reasonably confident that inflation will move back to its 2% objective over the medium term," the statement said. "This change in the forward guidance does not indicate that the (monetary policy) committee has decided on the timing of the initial increase in the target range." In her press conference, Fed Chair Janet Yellen said: "Just because we removed the word patient from the statement doesn't mean we are going to be impatient."
----------
The Swiss National Bank kept its monetary policy unchanged and projected a deep negative inflation this year. The central bank also downgraded its growth forecast as the discontinuation of currency ceiling and the subsequent strength of the franc weighed on activity. The SNB maintained the target range for the three-month libor between -1.25% and -0.25%. The interest rate on sight deposits with the SNB remained at -0.75% and the exemption thresholds remained unchanged, the bank said in a statement. The SNB reiterated that the Swiss franc is significantly overvalued and should continue to weaken over time.
----------
Greek Prime Minister Alexis Tsipras was set to hold crisis talks with top European officials in Brussels, amid fears that his country is running out of cash. The meeting is to be conducted on the margins of an EU summit, following reports that Greece and its creditors have hit an impasse in reform negotiations needed before Athens can access EUR7.2 billion left to its international bailout.
----------
Japan and China held a top-level security meeting on Thursday, the first in four years, amid soured ties over a territorial spat and differing views of wartime history. Foreign affairs and defence officials of the two countries were expected to discuss a mechanism to avoid unintended clashes at sea. "It can be said that Japan-China relations appear to be advancing gradually," Japanese Deputy Foreign Minister Shinsuke Sugiyama told the meeting in Tokyo, Kyodo News agency reported.
----------
Swiss authorities have so far frozen about USD403 million in connection with the massive corruption case around Brazilian oil giant Petrobras, the Swiss Attorney General Michael Lauber said. Lauber, who addressed reporters during a visit to Brasilia, said that, of that total, Swiss authorities have already approved the return to Brazil of about USD121 million. The seizure was the latest development in the unfolding USD3.7 billion scandal around the state-controlled Petrobras, Brazil's largest company, that has tarnished Brazilian President Dilma Rousseff and provoked massive public protests.
----------
Russian President Vladimir Putin said Ukrainians and Russians are a single people. "We in Russia always thought that Russians and Ukrainians are one people. And I believe so today," Putin told a rally on Red Square marking the first anniversary of Crimea's "unification" with Russia. Putin argued that Crimea and Russia did not unite for territory or strategic aims, but that the peninsula was "the source of our spirituality and statehood."
----------
Benjamin Netanyahu's Likud party confounded all expectations by scoring a victory in Israel's parliamentary elections, all but guaranteeing a third-consecutive term for the hardline premier. Likud was projected to take 29 or 30 seats in the 120-seat Knesset after almost 99% of the ballots were counted Wednesday. Its primary rival, the centre-left Zionist Camp, trailed with 24 seats. Netanyahu aides said the premier would start the work of forming a government "immediately," seeking to complete it in two or three weeks.
----------
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.